Scribe Therapeutics Inc.
NASDAQ:SCTXBiotechnology
Healthcare
$14.05 -4.80%
-$0.91 today
- Market cap
- $227.36M
- Beta
- 0.00
Volume 0.27M
Average 0.98M
SCTX Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
No reported Deferred Revenue (Non-current) figures are available to summarize.
Deferred Revenue (Non-current) history
Currency unavailable · from the balance sheet
No Deferred Revenue (Non-current) data reported for this period type.
Deferred Revenue (Non-current) vs competitors
How SCTX compares with its peers on the latest reported figures
No competitor Deferred Revenue (Non-current) figures are available to compare.
Balance Sheet
Currency unavailable
Scribe Therapeutics Inc.
NASDAQ:SCTX
Intrinsic Alpha fair value
Locked
Current Price
$14.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.